已收盤 05-08 16:00:00 美东时间
+5.790
+0.82%
默沙东 默沙东持续通过研发与收购扩展研发管线。今年3月,该公司斥资约67亿美元收购了Terns Pharmaceuticals,获得治疗慢性髓系白血病...
05-09 07:31
FACTBOX-Global pharma companies that have publicly announced Trump drug pricing agreements Changes dateline, updates paragraph 1, adds Regeneron's deal details May 4 (Reuters) - U.S. President Donald Trump secured agreements with 17 major pharmaceutical companies to bring U.S. prescription drug pric
05-04 22:45
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04
今日重点评级关注:HC Wainwright & Co.:维持Immunic"买入"评级,目标价从5美元升至22美元;花旗:维持ServiceNow"买入"评级,目标价从154美元升至158美元
05-01 10:49
Wells Fargo analyst Mohit Bansal maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Equal-Weight and lowers the price target from $825 to $800.
04-30 21:28
U.S. RESEARCH ROUNDUP-Alphabet, Amazon, Meta April 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alphabet, Amazon and Meta on Thursday. HIGHLIGHTS * Alphabet Inc GOOG.O : Oppenheimer raises target price to $425 from
04-30 15:23
Regeneron beats Q1 estimates as Eylea HD demand rises, while margins narrow and FDA decisions on manufacturing remain pending.
04-30 01:57
Crude oil rocketed nearly 6% on a stalled US-Iran standoff while stocks drifted lower ahead of the Fed decision and Big Tech earnings due after the bell.
04-30 00:34